BioWa is a U.S. subsidiary of Kyowa Kirin and the exclusive worldwide licensor of Potelligent® Technology, a proprietary technology that creates 100% fucose-free monoclonal antibodies that demonstrate a marked increase in antibody-dependent cellular cytotoxicity (ADCC). A critical function of the immune system, ADCC enhances the ability of antibodies to kill tumor cells. With BioWa’s technology, enhancement of monoclonal antibody (Mab) potency has been shown to increase up to 100 fold both in vitro and in vivo.
View Top Employees from BioWa, Inc.| Website | http://www.biowa.com |
| Revenue | $405000 |
| Employees | 9 (4 on RocketReach) |
| Founded | 2003 |
| Address | 510 Carnegie Center Suite 600, Princeton, New Jersey 08540, US |
| Phone | (609) 580-7500 |
| Industry | Biotechnology Research, Biotechnology, Pharmaceuticals, Healthcare |
| Web Rank | 6 Million |
| Keywords | Kyowa Kirin Uk, Kyowa Kirin Products Uk, Kyowa Kirin, Tostran 2 Gel, Kyowa Kirin Tostran Gel |
| Competitors | AstraZeneca México, Celgene, Cyclacel Limited, Enzon Pharmaceuticals, GPC Biotech AG |
| SIC | SIC Code 73 Companies, SIC Code 737 Companies |
| NAICS | NAICS Code 54151 Companies, NAICS Code 54 Companies, NAICS Code 541511 Companies, NAICS Code 5415 Companies, NAICS Code 541 Companies |
Looking for a particular BioWa, Inc. employee's phone or email?
BioWa, Inc. Questions
The BioWa, Inc. annual revenue was $405000 in 2024.
Sarah Fuller is the President of BioWa, Inc..
4 people are employed at BioWa, Inc..
BioWa, Inc. is based in Princeton, New Jersey.
The NAICS codes for BioWa, Inc. are [54151, 54, 541511, 5415, 541].
The SIC codes for BioWa, Inc. are [73, 737].
Top BioWa, Inc. Employees
-
5+5+
-
1
Related Companies
